Cargando…

Glucocorticoids improve severe or critical COVID-19 by activating ACE2 and reducing IL-6 levels

COVID-19 is a public health emergency that has rapidly spread to over 200 countries and regions, and no effective treatment has been established to date. Severe and critical cases have been associated with higher mortality due to acute respiratory distress syndrome (ARDS) and cytokine storm. Based o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiang, Zhen, Liu, Jialin, Shi, Dake, Chen, Wei, Li, Jun, Yan, Ranlin, Bi, Yufang, Hu, Weiguo, Zhu, Zhenggang, Yu, Yingyan, Yang, Zhitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378642/ https://www.ncbi.nlm.nih.gov/pubmed/32760206 http://dx.doi.org/10.7150/ijbs.47652

Ejemplares similares

A Novel Citrullinated Modification of Histone 3 and Its Regulatory Mechanisms Related to IPO-38 Antibody-Labeled Protein
por: Song, Shuzheng, et al.
Publicado: (2019)

Cross-Database Analysis Reveals Sensitive Biomarkers for Combined Therapy for ERBB2+ Gastric Cancer
por: Xiang, Zhen, et al.
Publicado: (2018)

Genetic Profiles Affect the Biological Effects of Serine on Gastric Cancer Cells
por: Li, Jun, et al.
Publicado: (2020)

A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis
por: Xiang, Zhen, et al.
Publicado: (2019)

Tracking cancer lesions on surgical samples of gastric cancer by artificial intelligent algorithms
por: Yang, Ruixin, et al.
Publicado: (2021)

Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways
por: Xiang, Zhen, et al.
Publicado: (2021)

A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids
por: Yang, Ruixin, et al.
Publicado: (2023)

The critical role of T cells in glucocorticoid-induced osteoporosis
por: Song, Lin, et al.
Publicado: (2020)

Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers
por: Yu, Yingyan
Publicado: (2021)

Glucocorticoids are double-edged sword in the treatment of COVID-19 and cancers
por: Yang, Ruixin, et al.
Publicado: (2021)

The tenocyte phenotype of human primary tendon cells in vitro is reduced by glucocorticoids
por: Spang, Christoph, et al.
Publicado: (2016)

Deciphering the balance of IL-6/IL-10 cytokines in severe to critical COVID-19 patients
por: Azaiz, Mouna Ben, et al.
Publicado: (2022)

A critical evaluation of glucocorticoids in the management of severe COVID-19
por: Solinas, Cinzia, et al.
Publicado: (2020)

MTA2 enhances colony formation and tumor growth of gastric cancer cells through IL-11
por: Zhou, Chenfei, et al.
Publicado: (2015)

Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder
por: Frodl, T, et al.
Publicado: (2012)

Glucocorticoid benefits the ventilatory function of severe/critical COVID-19 patients
por: Xiong, Xiaoming, et al.
Publicado: (2021)

Increased CSF levels of IL-1β, IL-6, and ACE in SARS-CoV-2–associated encephalitis
por: Bodro, Marta, et al.
Publicado: (2020)

Targeting IL-6 receptor reduces IgM levels and tumor growth in Waldenström macroglobulinemia
por: Han, Weiguo, et al.
Publicado: (2019)

A study of genes encoding cytokines (IL6, IL10, TNF), cytokine receptors (IL6R, IL6ST), and glucocorticoid receptor (NR3C1) and susceptibility to bronchopulmonary dysplasia
por: Huusko, Johanna M, et al.
Publicado: (2014)

Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity
por: von Zimmermann, Claudia, et al.
Publicado: (2021)

IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse
por: Li, Xiang, et al.
Publicado: (2016)

Critical Appraisal of Four IL-6 Immunoassays
por: Thompson, Dana K., et al.
Publicado: (2012)

Glucocorticoids and the Brain after Critical Illness
por: Hill, Alice R, et al.
Publicado: (2021)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

Systemic IL-6 and Severe Asthma
por: Lipworth, Brian, et al.
Publicado: (2020)

Role of IL-6 in Severe Inflammation
por: Inoue, Ken-ichiro, et al.
Publicado: (2021)

IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes
por: Skuratovskaia, Daria, et al.
Publicado: (2021)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience
por: Jiménez-Brítez, Gustavo, et al.
Publicado: (2020)

HBV replication is significantly reduced by IL-6
por: Kuo, Tzer-Min, et al.
Publicado: (2009)

Glucocorticoid therapy reduces ocular hypertension in active moderate-severe thyroid-associated orbitopathy
por: Tang, Chengyang, et al.
Publicado: (2022)

An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients
por: Saavedra, Danay, et al.
Publicado: (2020)

IL-1β, IL-6, and RANTES as Biomarkers of Chikungunya Severity
por: Ng, Lisa F. P., et al.
Publicado: (2009)

Aplastic anemia severity and IL-6 and IL-8 blood levels
por: Bhargawa, Sharvan Kumar, et al.
Publicado: (2022)

ACE2: The Key Molecule for Understanding the Pathophysiology of Severe and Critical Conditions of COVID-19: Demon or Angel?
por: Xiao, Li, et al.
Publicado: (2020)

Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
por: Sabater Molina, Maria, et al.
Publicado: (2022)

ACE and ACE2 Gene Variants Are Associated With Severe Outcomes of COVID-19 in Men
por: Martínez-Gómez, Laura E., et al.
Publicado: (2022)

Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
por: Faustine, Ingrid, et al.
Publicado: (2023)

Glucocorticoid-Glucocorticoid Receptor Response to Severe Acute Respiratory Syndrome Coronavirus 2*
por: Annane, Djillali, et al.
Publicado: (2021)

The efficacy of IL-6 inhibitor Tocilizumab in reducing severe COVID-19 mortality: a systematic review
por: Kaye, Avi Gurion, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f60vf2mq902d4jqlc1c93joqs3